Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Placenta Praevia

17 alpha-hydroxyprogesterone caproate has been researched along with Placenta Praevia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ali, MK; Attyia, KM; Shaamash, AH1

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Placenta Praevia

ArticleYear
Intramuscular 17α-hydroxyprogesterone caproate to decrease preterm delivery in women with placenta praevia: a randomised controlled trial.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2020, Volume: 40, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cesarean Section; Female; Gestational Age; Humans; Infant, Newborn; Injections, Intramuscular; Placenta Previa; Pregnancy; Premature Birth; Tocolytic Agents

2020